Emerging roles of nucleotide metabolism in cancer

DD Shi, MR Savani, KG Abdullah, SK McBrayer - Trends in cancer, 2023 - cell.com
Nucleotides are substrates for multiple anabolic pathways, most notably DNA and RNA
synthesis. Since nucleotide synthesis inhibitors began to be used for cancer therapy in the …

Glioblastoma metabolism: insights and therapeutic strategies

C Bernhard, D Reita, S Martin, N Entz-Werle… - International Journal of …, 2023 - mdpi.com
Tumor metabolism is emerging as a potential target for cancer therapies. This new approach
holds particular promise for the treatment of glioblastoma, a highly lethal brain tumor that is …

Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance

L Zarzuela, RV Durán, M Tomé - Molecular Oncology, 2023 - Wiley Online Library
Glioblastoma is the most common form of primary malignant brain tumor in adults and one of
the most lethal human cancers, with high recurrence and therapy resistance. Glioblastoma …

[HTML][HTML] Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets

AI Cortes Ballen, M Amosu, S Ravinder, J Chan… - Cells, 2024 - mdpi.com
Glioblastoma (GBM) is an aggressive and highly malignant primary brain tumor
characterized by rapid growth and a poor prognosis for patients. Despite advancements in …

Ginsenoside Rd alleviates early brain injury by inhibiting ferroptosis through cGAS/STING/DHODH pathway after subarachnoid hemorrhage

G Jiang, H Yang, C Li, N Liu, S Ma, B Jin, C Yan… - Free Radical Biology …, 2024 - Elsevier
Ferroptosis, a recently identified form of regulated cell death, is characterized by lipid
peroxidation and iron accumulation, plays a critical role in early brain injury after …

Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors

MMG Kes, F Morales-Rodriguez, EA Zaal… - Cell Reports …, 2024 - cell.com
Malignant rhabdoid tumor (MRT) is one of the most aggressive childhood cancers for which
no effective treatment options are available. Reprogramming of cellular metabolism is an …

Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma

S Wang, Y Li, Y Lin, J Li, L Guo, H Wang, X Lin, Z Liu… - Scientific Reports, 2024 - nature.com
Clear cell renal cell carcinoma (ccRCC) is a malignant tumor of the urinary system. To
explore the potential mechanisms of DHODH in ccRCC, we analyzed its molecular …

[HTML][HTML] A robust primary liver cancer subtype related to prognosis and drug response based on a multiple combined classifying strategy

J Deng, G Lai, C Zhang, K Li, W Zhu, B Xie, X Zhong - Heliyon, 2024 - cell.com
The recurrence or resistance to treatment of primary liver cancer (PLL) is significantly related
to the heterogeneity present within the tumor. In this study, we integrated prognosis risk …

The role of biomarkers in stage III non-small cell lung cancer

R Rosell, M González-Cao, M Ito… - Expert Review of …, 2023 - Taylor & Francis
Introduction Stage III non-small cell lung cancer (NSCLC) is a composite of the regional
spread of lung cancer with different levels of potential lymph node involvement and tumor …

Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T‐cell leukemia

C Ishikawa, N Mori - European Journal of Haematology, 2024 - Wiley Online Library
Objectives We aimed to determine the role of dihydroorotate dehydrogenase (DHODH) in
pathogenesis of adult T‐cell leukemia (ATL) caused by human T‐cell leukemia virus type 1 …